PMID- 35115003 OWN - NLM STAT- MEDLINE DCOM- 20220318 LR - 20220318 IS - 1472-6823 (Electronic) IS - 1472-6823 (Linking) VI - 22 IP - 1 DP - 2022 Feb 3 TI - The effect of periodic ketogenic diet on newly diagnosed overweight or obese patients with type 2 diabetes. PG - 34 LID - 10.1186/s12902-022-00947-2 [doi] LID - 34 AB - BACKGROUND: The ketogenic diet (KD) is characterized by fat as a substitute of carbohydrates for the primary energy source. There is a large number of overweight or obese people with type 2 diabetes mellitus (T2DM), while this study aims to observe periodic ketogenic diet for effect on overweight or obese patients newly diagnosed as T2DM. METHODS: A total of 60 overweight or obese patients newly diagnosed as T2DM were randomized into two groups: KD group, which was given ketogenic diet, and control group, which was given routine diet for diabetes, 30 cases in each group. Both dietary patterns lasted 12 weeks, and during the period, the blood glucose, blood lipid, body weight, insulin, and uric acid before and after intervention, as well as the significance for relevant changes, were observed. RESULTS: For both groups, the weight, BMI(body mass index), Waist, TG (triglyceride), TC(cholesterol), LDL (low-density lipoprotein cholesterol), HDL (high-density lipoprotein cholesterol), FBG (fasting glucose), FINS (fasting insulin), HbA1c (glycosylated hemoglobin) were decreased after intervention (P < 0.05), while the decrease rates in the KD group was more significant than the control group. However, UA(serum uric acid) in the KD group showed an upward trend, while in the control group was not changed significantly (P > 0.05).The willingness to adhere to the ketogenic diet over the long term was weaker than to the routine diet for diabetes. CONCLUSION: Among the overweight or obese patients newly diagnosed as type 2 diabetes mellitus, periodic ketogenic diet can not only control the body weight, but also control blood glucose and lipid, but long-term persistence is difficult. CI - (c) 2022. The Author(s). FAU - Li, Sumei AU - Li S AUID- ORCID: 0000-0002-6963-5309 AD - Department o f Endocrinology, Teaching Hospital, The First Hospital of Putian, Fujian Medical University, Putian, Fujian Province, People's Republic of China. ptsyy.lsm@163.com. FAU - Lin, Guoxin AU - Lin G AD - Department o f Endocrinology, Teaching Hospital, The First Hospital of Putian, Fujian Medical University, Putian, Fujian Province, People's Republic of China. FAU - Chen, Jinxing AU - Chen J AD - Department o f Endocrinology, Teaching Hospital, The First Hospital of Putian, Fujian Medical University, Putian, Fujian Province, People's Republic of China. FAU - Chen, Zhenxin AU - Chen Z AD - Department o f Endocrinology, Teaching Hospital, The First Hospital of Putian, Fujian Medical University, Putian, Fujian Province, People's Republic of China. FAU - Xu, Feipeng AU - Xu F AD - Department o f Endocrinology, Teaching Hospital, The First Hospital of Putian, Fujian Medical University, Putian, Fujian Province, People's Republic of China. FAU - Zhu, Feng AU - Zhu F AD - Department o f Endocrinology, Teaching Hospital, The First Hospital of Putian, Fujian Medical University, Putian, Fujian Province, People's Republic of China. FAU - Zhang, Jintian AU - Zhang J AD - Department of Pathology, Putian University, Medical University, Fujian, China. FAU - Yuan, Shouping AU - Yuan S AD - Department o f Endocrinology, Teaching Hospital, The First Hospital of Putian, Fujian Medical University, Putian, Fujian Province, People's Republic of China. LA - eng GR - 2020SY002/Putian Science and Technology Bureau/ PT - Journal Article PT - Randomized Controlled Trial DEP - 20220203 PL - England TA - BMC Endocr Disord JT - BMC endocrine disorders JID - 101088676 RN - 0 (Biomarkers) SB - IM MH - Adult MH - Biomarkers/blood MH - Diabetes Mellitus, Type 2/*diet therapy MH - *Diet, Ketogenic MH - Female MH - Humans MH - Male MH - Obesity/*diet therapy MH - Overweight/*diet therapy PMC - PMC8811985 OTO - NOTNLM OT - Being overweight. Type 2 diabetes OT - Ketogenic diet OT - Newly diagnosis OT - Obesity COIS- The authors declare that they have no competing interests. EDAT- 2022/02/05 06:00 MHDA- 2022/03/19 06:00 PMCR- 2022/02/03 CRDT- 2022/02/04 05:35 PHST- 2020/06/15 00:00 [received] PHST- 2022/01/25 00:00 [accepted] PHST- 2022/02/04 05:35 [entrez] PHST- 2022/02/05 06:00 [pubmed] PHST- 2022/03/19 06:00 [medline] PHST- 2022/02/03 00:00 [pmc-release] AID - 10.1186/s12902-022-00947-2 [pii] AID - 947 [pii] AID - 10.1186/s12902-022-00947-2 [doi] PST - epublish SO - BMC Endocr Disord. 2022 Feb 3;22(1):34. doi: 10.1186/s12902-022-00947-2.